Skip to main content
VRXA
NASDAQ Life Sciences

Key Shareholder David Deck Discloses 18% Stake in Veraxa Biotech Post-Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$10.64
Mkt Cap
$672.347M
52W Low
$7.82
52W High
$27.36
52W Position info
36% above low
Off High info
61% below high
Rel. Volume info
21× avg
Market data snapshot near publication time

VRXA sits 36% above its 52-week low of $7.82 on elevated volume (21× avg).

Summary

David Lukas Deck has disclosed an 18.0% ownership stake in Veraxa Biotech Holding AG, acquired as part of the recent business combination, signaling significant insider commitment.


Key Events · Ownership and Investor Activity · VRXA

  • Significant Ownership Stake

    David Lukas Deck now beneficially owns 25,502,836 ordinary shares, representing 18.0% of Veraxa Biotech Holding AG.

  • Post-Merger Acquisition

    The shares were acquired upon the closing of the business combination between Voyager Acquisition Corp. and Veraxa Biotech AG on June 10, 2026.

  • Long-Term Investment Intent

    The Reporting Person acquired the shares for investment purposes and is subject to a lock-up agreement restricting transfers for a specified period.

  • Performance-Based Earnout

    The Reporting Person is eligible to receive additional 'Earnout Shares' if the company's stock price reaches certain volume-weighted average price (VWAP) targets ($11.00, $12.50, $14.00) over the next three fiscal years.


Analysis · VRXA · Life Sciences

This filing reveals that David Lukas Deck, a significant individual shareholder, now holds an 18.0% stake in Veraxa Biotech Holding AG following its business combination. This substantial ownership, valued at over $271 million, demonstrates strong alignment with the company's long-term success, especially given the lock-up agreement and earn-out provisions tied to future share price performance.

How filings like this one have moved

In the 30 days to Nov 3, 2026, 50.3% of the 199 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VRXA was trading at $10.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $672.3M. The 52-week trading range was $7.82 to $27.36. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VRXA - Latest Insights

VRXA
Oct 13, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.08 info
Change: -$0.150 (-12%) info
Market Cap: $152.165M info
VRXA
Aug 10, 2026, 5:20 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.83
Real-time Price: $1.08 info
Change: -$0.750 (-41%) info
Market Cap: $152.165M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $1.08 info
Change: -$0.740 (-41%) info
Market Cap: $152.165M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $1.08 info
Change: -$0.740 (-41%) info
Market Cap: $152.165M info
VRXA
Jul 27, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.97
Real-time Price: $1.08 info
Change: -$0.890 (-45%) info
Market Cap: $152.165M info